首页> 美国卫生研究院文献>BMC Biotechnology >Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation
【2h】

Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation

机译:抗TLR2体内产生介导巨噬细胞表面TLR2表达的抑制和TLR2驱动的细胞活化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundToll-like receptor (TLR) 2 is a component of the innate immune system and senses specific pathogen associated molecular patterns (PAMPs) of both microbial and viral origin. Cell activation via TLR2 and other pattern recognition receptors (PRRs) contributes to sepsis pathology and chronic inflammation both relying on overamplification of an immune response. Intracellular antibodies expressed and retained inside the endoplasmatic reticulum (ER-intrabodies) are applied to block translocation of secreted and cell surface molecules from the ER to the cell surface resulting in functional inhibition of the target protein. Here we describe generation and application of a functional anti-TLR2 ER intrabody (αT2ib) which was generated from an antagonistic monoclonal antibody (mAb) towards human and murine TLR2 (T2.5) to inhibit the function of TLR2. αT2ib is a scFv fragment comprising the variable domain of the heavy chain and the variable domain of the light chain of mAb T2.5 linked together by a synthetic (Gly4Ser)3 amino acid sequence.
机译:背景Toll样受体(TLR)2是先天免疫系统的一个组成部分,可感知微生物和病毒来源的特定病原体相关分子模式(PAMP)。通过TLR2和其他模式识别受体(PRR)激活的细胞会导致败血症病理和慢性炎症,这都依赖于免疫反应的过度扩增。表达并保留在内质网内部的细胞内抗体(ER内体)可用于阻止分泌的和细胞表面分子从ER转运到细胞表面,从而导致靶蛋白的功能受到抑制。在这里,我们描述了功能性抗TLR2 ER抗体(αT2ib)的产生和应用,该抗体由针对人和小鼠TLR2(T2.5)的拮抗性单克隆抗体(mAb)来抑制TLR2的功能。 αT2ib是一个scFv片段,包含通过合成(Gly4Ser)3氨基酸序列连接在一起的mAb T2.5的重链可变区和轻链可变区。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号